Pharma & Capital Market Stocks Can Beat Nifty? Feroze Azeez Shares His Long-Term Investment Picks

Pharma and capital market infrastructure could be among the strongest long-term investment themes, according to market experts. In this Business Today discussion, Feroze Azeez, Joint CEO, Anand Rathi Wealth, explains why the pharma sector may outperform the Nifty over the next few years, supported by stable US generic pricing, better earnings, and strong growth in CDMO businesses. He also highlights the potential of capital market-related companies as India's financialization continues to grow. Watch this detailed analysis to understand the sector outlook, key growth drivers, and the long-term opportunities these themes could offer investors.